COPENHAGEN—Health authorities in Denmark said on Friday that COVID-19 vaccines from AstraZeneca and Johnson & Johnson would remain excluded from the country’s vaccine roll-out following a review of new safety data. “The balance between possible benefit and possible harmful effects is still not favorable, even when we include assumptions in our analyses that benefit the…
AstraZeneca and Pfizer Vaccines Effective Against Delta and Kappa Strains of CCP Virus: Study
A new study suggests that COVID-19 vaccines made by AstraZeneca and the Pfizer-BioNTech alliance are broadly effective against the highly contagious Delta and Kappa strains of the CCP (Chinese Communist Party) virus, the pathogen that causes COVID-19. The Oxford University study, of which a peer-reviewed pre-proof has been published in Cell (pdf), sought to gauge…
Victoria to Lead Clinical Trials of Australia’s First Locally Made mRNA Vaccine
Australia’s first locally developed mRNA COVID-19 vaccine has been created in Victoria and will begin phase 1 trials within months. Acting Victorian Premier James Merlino announced on Sunday that the state government would invest $5 million into the Monash Institute of Pharmaceutical Sciences (MIPS) to manufacture doses of mRNA vaccine candidates. “This is an incredibly…
Australia Stops Recommending AstraZeneca to Under 60s
The Australian government on Thursday changed its CCP virus immunisation advice to recommend that AstraZeneca only be recommended for people aged 60 and over. This comes after experts found new evidence to suggest that there is a much higher risk of a rare but serious blood clot condition known as thrombosis and thrombocytopenia syndrome (TTS) in the…
AstraZeneca Antibody Cocktail Fails to Prevent COVID-19 in Large Trial
AstraZeneca said on Tuesday a late-stage trial failed to provide evidence that its COVID-19 antibody therapy protected people who had contact with an infected person from the disease, a small setback in its efforts to find alternatives to vaccines. The study assessed whether the therapy, a cocktail of two types of antibodies, could prevent adults…
EMA Official Says AstraZeneca Shots Have Good Risk-Benefit Profile for Over 60s
MILAN—The head of the EU drug regulator’s COVID-19 task force said on Sunday that AstraZeneca’s coronavirus vaccine had a favorable risk-benefit profile for all age groups and particularly for those aged over 60. Italian newspaper La Stampa earlier quoted European Medicines Agency (EMA) task force chief Marco Cavaleri as saying countries should avoid giving the…
AstraZeneca Shots Should Be Halted for Over-60s Too: EU Official
MILAN, Italy—Countries should also avoid giving the AstraZeneca coronavirus vaccine to people over 60, the head of the EU drug regulator’s COVID-19 task force was quoted on Sunday as saying, amid fears over rare blood clotting and as more vaccines become available. The European Medicines Agency (EMA) considers the AstraZeneca shot safe for all age…
AstraZeneca Jab Causes ‘Slightly Increased Risk’ of Bleeding: UK Study
The Oxford/AstraZeneca CCP virus vaccine is linked to “slightly increased risk of some bleeding disorders,” British researchers have found. Through an analysis of people who received a first dose of the AstraZeneca or Pfizer/BioNTech vaccine, researchers at the University of Edinburgh found a small increased risk of an autoimmune bleeding disorder known as immune thrombocytopenic…
Western Australia and South Australia Extend COVID-19 Vaccine Rollout
Both Western Australia and South Australia have expanded their COVID-19 vaccine rollout programs. Residents in West Australia aged 30 to 49 will be able to receive the Pfizer vaccine from this Thursday, while people aged above 50 will continue to receive the AstraZeneca (AZ) vaccine. Bookings of Pfizer vaccines are now available at state-run clinics…
NDIS Participants, Indigenous Aussies, and All Top End Territorians Over 16 Now Eligible for Vaccinations
All Aboriginal and Torres Strait Islanders aged over 16, as well as all National Disability Insurance Scheme (NDIS) participants aged over 16 and all residents of the Northern Territory, will now be eligible to access the CCP virus vaccines. This comes after the national cabinet approved the expansion last week to speed up the vaccine rollout…
US News
RSS Error: A feed could not be found at `https://www.theepochtimes.com/c-us/feed`; the status code is `200` and content-type is `text/html; charset=utf-8`